Martin Olin

Chief Executive Officer bij BERGENBIO ASA

55 jaar

Health Technology

Finance

Consumer Services

Momenteel actieve connecties

Naam	Geslacht	Leeftijd	Verwante bedrijven	Samenwerking
Albert Cha	M	51	ASCENDIS PHARMA A/S	10 jaar
Adam Sinding Steensberg	M	50	CESSATECH A/S	4 jaar
Stefan Scheding	M	62	ACOUSORT AB	12 jaar
Lars Thomas Laurell	M	63	ACOUSORT AB	13 jaar
Flemming Steen Jensen	M	63	CESSATECH A/S ASCENDIS PHARMA A/S	9 jaar
Peter Birk	M	59	CESSATECH A/S	4 jaar
James Barnes	M	-	BERGENBIO ASA	5 jaar
Rune Skeie	M	51	BERGENBIO ASA	6 jaar
Scott Smith	M	50	ASCENDIS PHARMA A/S	8 jaar
Lisa Bright	F	56	ASCENDIS PHARMA A/S	7 jaar
Karin Garre	M	67	Symphogen A/S Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark.	6 jaar
Karsten Munk Knudsen	M	53	NOVO NORDISK A/S	25 jaar
Henrik Ehlers Wulff	M	54	NOVO NORDISK A/S	25 jaar
Charlotte Videbaek	M	62	CESSATECH A/S	4 jaar
Christophe Thurieau	M	-	Symphogen A/S Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark.	4 jaar
Sveinung Hole	M	57	BERGENBIO ASA	14 jaar
Katherine J. Flagg	F	-	ACOUSORT AB	3 jaar
Torsten Freltoft	M	66	ACOUSORT AB	10 jaar
Sally Bennett	M	52	BERGENBIO ASA	4 jaar
Nigel McCracken	M	-	BERGENBIO ASA	3 jaar
Louise Bak	F	-	CESSATECH A/S	3 jaar
Steen Henneberg	M	75	CESSATECH A/S	4 jaar
Jes Trygved	M	51	CESSATECH A/S	4 jaar
Gayle Mills	F	69	BERGENBIO ASA	3 jaar
Cristina Oliva	M	-	BERGENBIO ASA	2 jaar
Debbie Molyneux	F	-	BERGENBIO ASA	5 jaar
Debra Stephanie Barker	M	61	BERGENBIO ASA	5 jaar
Anders Lennart Tullgren	M	63	BERGENBIO ASA	2 jaar
Gunnar Telhammar	M	63	ACOUSORT AB	8 jaar
Camilla Sylvest	F	52	NOVO NORDISK A/S	28 jaar
Rachel Curtis Gravesen	F	55	CESSATECH A/S	2 jaar
Graham Morrell	M	-	BERGENBIO ASA	-

Meer zien

Relatiegrafiek

Connectie in verschillende bedrijven

Oude connecties

Naam	Geslacht	Leeftijd	Verwante bedrijven	Samenwerking
Kirsten Drejer	M	68	Symphogen A/S Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. NOVO NORDISK A/S	25 jaar
Jakob Riis	M	58	NOVO NORDISK A/S	21 jaar
Birgitte Volck	M	61	ASCENDIS PHARMA A/S	7 jaar
Thomas Feldthus	M	64	NOVO NORDISK A/S Symphogen A/S Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark.	16 jaar
Ulla Hald Buhl	F	60	CESSATECH A/S	1 jaar
Rafaèle Elisabeth Tordjman	M	54	ASCENDIS PHARMA A/S	10 jaar
Mads Laustsen	M	67	Symphogen A/S Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark.	5 jaar
Stener Kvinnsland	M	76	BERGENBIO ASA	7 jaar
Jesper Brandgaard	M	60	NOVO NORDISK A/S	20 jaar
Jonathan Silverstein	M	57	ASCENDIS PHARMA A/S	-
Kurt Anker Nielsen	M	78	NOVO NORDISK A/S	13 jaar
Hani Gabra	M	-	BERGENBIO ASA	3 jaar
James Healy	M	58	ASCENDIS PHARMA A/S	8 jaar
E. Gwyn Thomas	M	-	BERGENBIO ASA	1 jaar
Benedikte Bandak	F	-	CESSATECH A/S	-
Grethe Nørskov Rasmussen	M	62	NOVO NORDISK A/S	11 jaar
Carmen Valcarce	M	-	NOVO NORDISK A/S	-
Alison Messom	M	52	BERGENBIO ASA	2 jaar
Peter Nordkild	M	69	NOVO NORDISK A/S	2 jaar
Patrick Loustau	M	61	NOVO NORDISK A/S	14 jaar
Hanne Damgaard Jensen	F	-	NOVO NORDISK A/S	4 jaar
Christopher Yallop	M	-	NOVO NORDISK A/S	6 jaar
Robert Frederick Caspari	M	78	NOVO NORDISK A/S	4 jaar
Anna Héléne Barnekow	F	60	NOVO NORDISK A/S	2 jaar
Neil Ringdahl	M	-	ASCENDIS PHARMA A/S	-
Annette Stube	F	57	NOVO NORDISK A/S	11 jaar
René Djurup	M	-	NOVO NORDISK A/S	4 jaar
Jette Traulsen	M	-	NOVO NORDISK A/S	5 jaar
Christoffer Søderberg	M	-	Symphogen A/S Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark.	-
Gitte L. Pedersen	F	61	NOVO NORDISK A/S	10 jaar
Zaiton binti Jamaluddin	F	65	NOVO NORDISK A/S	8 jaar
Thomas A. Larson	M	62	ASCENDIS PHARMA A/S	-
Gro Gausdal	M	-	BERGENBIO ASA	8 jaar
Bettina Nygaard Nielsen	M	47	CESSATECH A/S	-
Niels Svenstrup	M	54	ASCENDIS PHARMA A/S	2 jaar
Etienne Adriansen	M	60	CESSATECH A/S	-
Bernhard R. M. Ehmer	M	69	Symphogen A/S Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark.	2 jaar
Michael Beckert	M	-	ASCENDIS PHARMA A/S	7 jaar
Peder Holk Nielsen	M	67	NOVO NORDISK A/S	5 jaar
Göran Albert Ando	M	75	Symphogen A/S Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark.	-
Valeta A. Gregg	M	72	NOVO NORDISK A/S	5 jaar
Anker Gunvald Lundemose	M	63	NOVO NORDISK A/S	4 jaar
Jonathan Leff	M	66	ASCENDIS PHARMA A/S	3 jaar
Jørgen Wedel	M	75	NOVO NORDISK A/S	12 jaar
Jan Ulf Sigvar J. Johansson	M	79	NOVO NORDISK A/S	7 jaar
Ronald Eastman	M	71	Symphogen A/S Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark.	-
Jeffrey H. Buchalter	M	67	Symphogen A/S Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark.	-
Bruce Carter	M	80	NOVO NORDISK A/S	4 jaar
Jan Öhrström	M	67	NOVO NORDISK A/S	9 jaar
Peter Helt Jacobsen Haahr	M	56	Symphogen A/S Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark.	-
Martin Auster	M	49	ASCENDIS PHARMA A/S	2 jaar
Mads Krogsgaard Thomsen	M	63	Symphogen A/S Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark.	-
Christian Hansen	M	58	NOVO NORDISK A/S	7 jaar
Per Falholt	M	65	NOVO NORDISK A/S	16 jaar
Thomas Dyrberg	M	69	NOVO NORDISK A/S	10 jaar
Christian Gröndahl	M	60	NOVO NORDISK A/S	14 jaar
Mark Brennan	M	61	ASCENDIS PHARMA A/S	-
Søren Lemonius	M	59	Symphogen A/S Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark.	-
Steen Riisgaard	M	73	NOVO NORDISK A/S	21 jaar
Edwin de Graaf	M	-	ASCENDIS PHARMA A/S	-
Jens Jesper Ovesen	M	67	NOVO NORDISK A/S	4 jaar
Finn M. Ulrich	M	-	NOVO NORDISK A/S	8 jaar
Anders Hedegaard	M	63	NOVO NORDISK A/S	9 jaar
Per Toft Valstorp	M	75	NOVO NORDISK A/S	14 jaar
Jan Mikkelsen	M	65	NOVO NORDISK A/S	11 jaar
Martin Linde	M	53	ACOUSORT AB	6 jaar
Susanne Hayes	F	-	NOVO NORDISK A/S	10 jaar

Statistieken

Land	Connecties	% van het totaal
Denemarken	77	77.78%
Noorwegen	16	16.16%
Zweden	6	6.06%

Ouderdom van de connecties

Actief

Verleden

Man

Vrouw

Besturend

Uitvoerend

Oorsprong van de connecties

Beurs
Insiders
Martin Olin
Persoonlijk netwerk